These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8516947)

  • 21. CD8+ host cells infiltrate the intestinal mucosa after allogeneic small bowel transplantation even in the absence of acute rejection.
    Nüssler NC; Cicalese L; Hoffman RA; Rastellini C; Neuhaus P; Simmons RL; Schraut WH
    Transplant Proc; 1996 Oct; 28(5):2456. PubMed ID: 8907898
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of brequinar sodium on cynomolgus monkeys: immunosuppression and pharmacokinetics.
    Jaffee BD; Jones EA; Zajac I; Magolda RL; Cramer DV; Makowka L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):710-1. PubMed ID: 8438449
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of liver allograft rejection in rats by a short course of therapy with Brequinar Sodium.
    Cramer DV; Knoop M; Chapman FA; Wa GD; Jaffee BD; Makowka L
    Transplantation; 1992 Oct; 54(4):752-3. PubMed ID: 1412774
    [No Abstract]   [Full Text] [Related]  

  • 24. Phenolic nortriterpene demethylzeylasteral: a new immunosuppressive component of Tripterygium Wilfordii Hook f.
    Tamaki T; Kawamura A; Komatsu Y; Kawamura H; Maruyama H; Morota T
    Transplant Proc; 1996 Jun; 28(3):1379-80. PubMed ID: 8658703
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of brequinar sodium for transplantation.
    Cramer DV; Chapman FA; Makowka L
    Ann N Y Acad Sci; 1993 Nov; 696():216-26. PubMed ID: 8109829
    [No Abstract]   [Full Text] [Related]  

  • 26. Brequinar sodium.
    Cramer DV
    Pediatr Nephrol; 1995; 9 Suppl():S52-5. PubMed ID: 7492488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent immunosuppressive effects by a newly synthesized compound KF20444.
    Ito T; Okawa A; Sawai T; Yumiba T; Maeda A; Tori M; Nakata S; Nakajima H; Sato S; Matsuda H
    Transplant Proc; 1999 Nov; 31(7):2792-3. PubMed ID: 10578294
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporin A.
    Morris PJ
    Transplantation; 1981 Nov; 32(5):349-54. PubMed ID: 6460358
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model.
    Yin D; Ma LL; Blinder L; Shen J; Sankary H; Williams JW; Chong AS
    J Immunol; 1998 Aug; 161(4):2044-51. PubMed ID: 9712078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Historical development of brequinar sodium as a new immunosuppressive drug for transplantation.
    Makowka L; Chapman F; Cramer DV
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):2-7. PubMed ID: 8516937
    [No Abstract]   [Full Text] [Related]  

  • 31. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
    Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
    Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different immune effects on cardiac allografts and xenografts induced by neonatal intrathymic inoculation with allogeneic and xenogeneic antigens.
    Shen Z; Pelletier S; Mohiuddin M; Yokoyama H; Reiss GR; DiSesa VJ
    J Heart Lung Transplant; 1996 Oct; 15(10):1034-8. PubMed ID: 8913921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of xenograft reactions in rodents and other small laboratory species.
    Cramer DV; Wu GD; Makowka L
    Transplant Proc; 1993 Oct; 25(5):2846-7. PubMed ID: 8212256
    [No Abstract]   [Full Text] [Related]  

  • 34. Brequinar sodium.
    Cramer DV
    Transplant Proc; 1996 Apr; 28(2):960-3. PubMed ID: 8623481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts.
    Walgenbach KJ; Heeckt PF; Stanson JD; Whiteside TL; Bauer AJ
    Transplant Proc; 1996 Oct; 28(5):2454. PubMed ID: 8907896
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
    Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
    Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
    [No Abstract]   [Full Text] [Related]  

  • 37. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat.
    Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK
    Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
    Schorlemmer HU; Schwab W; Ruuth E; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182
    [No Abstract]   [Full Text] [Related]  

  • 39. The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
    Renna Molajoni E; Cinti P; Evangelista B; Poli L; Cocciolo P; Berloco P; Cortesini R
    Transplant Proc; 1996 Feb; 28(1):402-3. PubMed ID: 8644290
    [No Abstract]   [Full Text] [Related]  

  • 40. Control of mouse-to-rat skin xenograft rejection by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3037-9. PubMed ID: 8962179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.